Summary

The research team projects that the NK-1 Receptor Antagonists market size will grow from XXX in 2025 to XXX by 2030, at an estimated CAGR of XX. The base year considered for the study is 2024, and the market size is projected from 2025 to 2030.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Merck
TerSera Therapeutics
Helsinn Healthcare
Heron Therapeutics
Sandoz
Glenmark
Torrent Pharmaceuticals
Steriscience
Mylan
Fresenius Kabi
MSN
Teva
Eugia Pharma
Lupin
Dr. Reddy's Laboratories
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Beijing Sihuan Pharmaceutical
Yichang Humanwell Pharmaceutical
Hansoh Pharma

By Type
Aprepitant
Rolapitant
Fosaprepitant
Netupitant
Maropitant
Other

By Application
Chemotherapy-induced Nausea and Vomiting (CINV)
Postoperative Nausea and Vomiting (PONV)
Other

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of NK-1 Receptor Antagonists 2019-2024, and development forecast 2025-2030 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2024 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2025-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the NK-1 Receptor Antagonists Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the NK-1 Receptor Antagonists Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the NK-1 Receptor Antagonists market in 2024. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NK-1 Receptor Antagonists Revenue
1.4 Market Analysis by Type
1.4.1 Global NK-1 Receptor Antagonists Market Size Growth Rate by Type: 2025 VS 2030
1.4.2 Aprepitant
1.4.3 Rolapitant
1.4.4 Fosaprepitant
1.4.5 Netupitant
1.4.6 Maropitant
1.4.7 Other
1.5 Market by Application
1.5.1 Global NK-1 Receptor Antagonists Market Share by Application: 2025-2030
1.5.2 Chemotherapy-induced Nausea and Vomiting (CINV)
1.5.3 Postoperative Nausea and Vomiting (PONV)
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global NK-1 Receptor Antagonists Market
1.8.1 Global NK-1 Receptor Antagonists Market Status and Outlook (2019-2030)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
1.9 Global Market Growth Prospects
1.9.1 Global NK-1 Receptor Antagonists Revenue Estimates and Forecasts (2019-2030)
1.9.2 Global NK-1 Receptor Antagonists Production Capacity Estimates and Forecasts (2019-2030)
1.9.3 Global NK-1 Receptor Antagonists Production Estimates and Forecasts (2019-2030)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material
2.2 Manufacturing Cost Structure Analysis of NK-1 Receptor Antagonists
2.3 Manufacturing Process Analysis of NK-1 Receptor Antagonists
2.4 Industry Chain Structure of NK-1 Receptor Antagonists
3 Development and Manufacturing Plants Analysis of NK-1 Receptor Antagonists
3.1 Top Manufacturers Headquarters, Rank by NK-1 Receptor Antagonists Production
3.2 Global NK-1 Receptor Antagonists Manufacturing Plants Distribution and Commercial Production Date
4 Market Competition by Manufacturers
4.1 Global NK-1 Receptor Antagonists Production Capacity Market Share by Manufacturers (2019-2024)
4.2 Global NK-1 Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
4.3 Global NK-1 Receptor Antagonists Average Price by Manufacturers (2019-2024)
4.4 Manufacturers NK-1 Receptor Antagonists Production Sites, Area Served, Product Type
5 NK-1 Receptor Antagonists Regional Market Analysis
5.1 NK-1 Receptor Antagonists Production by Regions
5.1.1 Global NK-1 Receptor Antagonists Production by Regions (2019-2024)
5.1.2 Global NK-1 Receptor Antagonists Revenue by Regions
5.2 NK-1 Receptor Antagonists Consumption by Regions
5.3 North America NK-1 Receptor Antagonists Market Analysis
5.3.1 North America NK-1 Receptor Antagonists Production
5.3.2 North America NK-1 Receptor Antagonists Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America NK-1 Receptor Antagonists Import and Export
5.4 East Asia NK-1 Receptor Antagonists Market Analysis
5.4.1 East Asia NK-1 Receptor Antagonists Production
5.4.2 East Asia NK-1 Receptor Antagonists Revenue
5.4.3 Key Manufacturers in East Asia
5.4.4 East Asia NK-1 Receptor Antagonists Import & Export
5.5 Europe NK-1 Receptor Antagonists Market Analysis
5.5.1 Europe NK-1 Receptor Antagonists Production
5.5.2 Europe NK-1 Receptor Antagonists Revenue
5.5.3 Key Manufacturers in Europe
5.5.4 Europe NK-1 Receptor Antagonists Import & Export
5.6 South Asia NK-1 Receptor Antagonists Market Analysis
5.6.1 South Asia NK-1 Receptor Antagonists Production
5.6.2 South Asia NK-1 Receptor Antagonists Revenue
5.6.3 Key Manufacturers in South Asia
5.6.4 South Asia NK-1 Receptor Antagonists Import & Export
5.7 Southeast Asia NK-1 Receptor Antagonists Market Analysis
5.7.1 Southeast Asia NK-1 Receptor Antagonists Production
5.7.2 Southeast Asia NK-1 Receptor Antagonists Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia NK-1 Receptor Antagonists Import & Export
5.8 Middle East NK-1 Receptor Antagonists Market Analysis
5.8.1 Middle East NK-1 Receptor Antagonists Production
5.8.2 Middle East NK-1 Receptor Antagonists Revenue
5.8.3 Key Manufacturers in Middle East
5.8.4 Middle East NK-1 Receptor Antagonists Import & Export
5.9 Africa NK-1 Receptor Antagonists Market Analysis
5.9.1 Africa NK-1 Receptor Antagonists Production
5.9.2 Africa NK-1 Receptor Antagonists Revenue
5.9.3 Key Manufacturers in Africa
5.9.4 Africa NK-1 Receptor Antagonists Import & Export
5.10 Oceania NK-1 Receptor Antagonists Market Analysis
5.10.1 Oceania NK-1 Receptor Antagonists Production
5.10.2 Oceania NK-1 Receptor Antagonists Revenue
5.10.3 Key Manufacturers in Oceania
5.10.4 Oceania NK-1 Receptor Antagonists Import & Export
5.11 South America NK-1 Receptor Antagonists Market Analysis
5.11.1 South America NK-1 Receptor Antagonists Production
5.11.2 South America NK-1 Receptor Antagonists Revenue
5.11.3 Key Manufacturers in South America
5.11.4 South America NK-1 Receptor Antagonists Import & Export
6 NK-1 Receptor Antagonists Sales Market by Type (2019-2030)
6.1 Global NK-1 Receptor Antagonists Historic Market Size by Type (2019-2024)
6.2 Global NK-1 Receptor Antagonists Forecasted Market Size by Type (2025-2030)
7 NK-1 Receptor Antagonists Consumption Market by Application(2019-2030)
7.1 Global NK-1 Receptor Antagonists Historic Market Size by Application (2019-2024)
7.2 Global NK-1 Receptor Antagonists Forecasted Market Size by Application (2025-2030)
8 Company Profiles and Key Figures in NK-1 Receptor Antagonists Business
8.1 Merck
8.1.1 Merck Company Profile
8.1.2 Merck NK-1 Receptor Antagonists Product Specification
8.1.3 Merck NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2 TerSera Therapeutics
8.2.1 TerSera Therapeutics Company Profile
8.2.2 TerSera Therapeutics NK-1 Receptor Antagonists Product Specification
8.2.3 TerSera Therapeutics NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3 Helsinn Healthcare
8.3.1 Helsinn Healthcare Company Profile
8.3.2 Helsinn Healthcare NK-1 Receptor Antagonists Product Specification
8.3.3 Helsinn Healthcare NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4 Heron Therapeutics
8.4.1 Heron Therapeutics Company Profile
8.4.2 Heron Therapeutics NK-1 Receptor Antagonists Product Specification
8.4.3 Heron Therapeutics NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5 Sandoz
8.5.1 Sandoz Company Profile
8.5.2 Sandoz NK-1 Receptor Antagonists Product Specification
8.5.3 Sandoz NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6 Glenmark
8.6.1 Glenmark Company Profile
8.6.2 Glenmark NK-1 Receptor Antagonists Product Specification
8.6.3 Glenmark NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7 Torrent Pharmaceuticals
8.7.1 Torrent Pharmaceuticals Company Profile
8.7.2 Torrent Pharmaceuticals NK-1 Receptor Antagonists Product Specification
8.7.3 Torrent Pharmaceuticals NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8 Steriscience
8.8.1 Steriscience Company Profile
8.8.2 Steriscience NK-1 Receptor Antagonists Product Specification
8.8.3 Steriscience NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9 Mylan
8.9.1 Mylan Company Profile
8.9.2 Mylan NK-1 Receptor Antagonists Product Specification
8.9.3 Mylan NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10 Fresenius Kabi
8.10.1 Fresenius Kabi Company Profile
8.10.2 Fresenius Kabi NK-1 Receptor Antagonists Product Specification
8.10.3 Fresenius Kabi NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.11 MSN
8.11.1 MSN Company Profile
8.11.2 MSN NK-1 Receptor Antagonists Product Specification
8.11.3 MSN NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.12 Teva
8.12.1 Teva Company Profile
8.12.2 Teva NK-1 Receptor Antagonists Product Specification
8.12.3 Teva NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.13 Eugia Pharma
8.13.1 Eugia Pharma Company Profile
8.13.2 Eugia Pharma NK-1 Receptor Antagonists Product Specification
8.13.3 Eugia Pharma NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.14 Lupin
8.14.1 Lupin Company Profile
8.14.2 Lupin NK-1 Receptor Antagonists Product Specification
8.14.3 Lupin NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.15 Dr. Reddy's Laboratories
8.15.1 Dr. Reddy's Laboratories Company Profile
8.15.2 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product Specification
8.15.3 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.16 Chia Tai Tianqing Pharmaceutical
8.16.1 Chia Tai Tianqing Pharmaceutical Company Profile
8.16.2 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product Specification
8.16.3 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.17 Qilu Pharmaceutical
8.17.1 Qilu Pharmaceutical Company Profile
8.17.2 Qilu Pharmaceutical NK-1 Receptor Antagonists Product Specification
8.17.3 Qilu Pharmaceutical NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.18 Beijing Sihuan Pharmaceutical
8.18.1 Beijing Sihuan Pharmaceutical Company Profile
8.18.2 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product Specification
8.18.3 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.19 Yichang Humanwell Pharmaceutical
8.19.1 Yichang Humanwell Pharmaceutical Company Profile
8.19.2 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product Specification
8.19.3 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.20 Hansoh Pharma
8.20.1 Hansoh Pharma Company Profile
8.20.2 Hansoh Pharma NK-1 Receptor Antagonists Product Specification
8.20.3 Hansoh Pharma NK-1 Receptor Antagonists Production Capacity, Revenue, Price and Gross Margin (2019-2024)
9 Production and Supply Forecast
9.1 Global Forecasted Production of NK-1 Receptor Antagonists (2025-2030)
9.2 Global Forecasted Revenue of NK-1 Receptor Antagonists (2025-2030)
9.3 Global Forecasted Price of NK-1 Receptor Antagonists (2019-2030)
9.4 Global Forecasted Production of NK-1 Receptor Antagonists by Region (2025-2030)
9.4.1 North America NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.2 East Asia NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.3 Europe NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.4 South Asia NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.5 Southeast Asia NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.6 Middle East NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.7 Africa NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.8 Oceania NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.9 South America NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.4.10 Rest of the World NK-1 Receptor Antagonists Production, Revenue Forecast (2025-2030)
9.5 Forecast by Type and by Application (2025-2030)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2025-2030)
9.5.2 Global Forecasted Consumption of NK-1 Receptor Antagonists by Application (2025-2030)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.2 East Asia Market Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.3 Europe Market Forecasted Consumption of NK-1 Receptor Antagonists by Countriy
10.4 South Asia Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.5 Southeast Asia Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.6 Middle East Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.7 Africa Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.8 Oceania Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.9 South America Forecasted Consumption of NK-1 Receptor Antagonists by Country
10.10 Rest of the world Forecasted Consumption of NK-1 Receptor Antagonists by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities and Drivers
12.3 Challenges
12.4 Porter's Five Forces Analysis
13 Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer